HHS/CMMI Response to Executive Order: New models to cut drug costs
The CMS Innovation Center rolled out three new payment models intended to lower drug costs. One involves a list of generic drugs for which the out-of-pocket Part D costs will be capped at $2 a month per drug; the second will help expand access to cutting-edge cell and gene therapies for people with Medicaid. The third would create new payment methods for drugs put on the market via accelerated approval. The Innovation Center did not provide a timeline. (Fierce Healthcare; Innovation Center Fact Sheet)
Evidence & Innovation
Data privacy: FTC fines GoodRX 1.5M, launches tech office
In Case You Missed It!
Katherine H. Capps, Co-Founder and GTMRx Board Member will present ” A Better Way to Manage Medications: CMM + Pharmacogenomic Testing ” at PMLS Updates in Precision Medicine and Pharmacogenomics – March 2-3, 2023
We are delighted to be a part of the upcoming PMLS Updates in Precision Medicine and Pharmacogenomics event in Orlando, March 2-3, 2023. Join over 40 thought leaders for two days of discussions and networking. Only a few weeks left to take advantage of the 20% discount. Use code SPEAKER20 when registering.
NEW 2022 GTMRx Resource | Comprehensive Medication Management via Telehealth Modality in Team-Based Care:A Review of the Evidence on Quality, Access and Costs, December 2022